Use of antiretroviral therapy during pregnancy among HIV-infected women attending an urban care centre by Ssewankambo, F et al.
POSTER PRESENTATION Open Access
Use of antiretroviral therapy during pregnancy
among HIV-infected women attending an urban
care centre
F Ssewankambo
1*, C Nalugwa
1, J Sempa
2, J Walusimbi
1, A Kambugu
1
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Background
With the large international mobilization of resources
against HIV/AIDS and the great improvement of ARV
drug access within the last 7 years in resource-limited
countries, more HIV-infected people are expected to
access antiretroviral therapy (ART) including pregnant
women. However, coverage of PMTCT services in many
Sub-Saharan countries is still low. The aim of the study
was to characterize and estimate the number of preg-
nant women who were receiving ART at adult Infectious
Diseases Institute clinic (AIDC).
Methods
We retrospectively analyzed routinely collected data in
HIV/AIDS clinic within a period of Jan-2008 to Oct
2009 among HIV positive pregnant women attending
care at (AIDC). Descriptive data analyses were con-
ducted to characterize and estimate the number of preg-
nant women on ART at AIDC.
Summary of results
A total of 649 pregnant women were recorded with med-
ian age 30(IQR: 26, 33) years and (196/427) 45% had
unintended pregnancy. Ninety-five percent had formal
education while 84% were married. Their health status in
regard to current median CD4 was 376 (IQR: 282, 550)
cells/mm
3 while 315 women were on ART (85% NVP-
based & 14% PI-based). Among 208 women who had
reported to have delivered, only (83/208) 40% knew the
sero-status of their babies (79/83) 95% HIV-ve and (4/83)
5% HIV+ve).
Conclusions
Our results indicate inadequate follow-up of PMTCT
service utilization and low documentation of pregnancy
outcomes among HIV positive pregnant women attend-
ing care. There is a need to strengthen PMTCT and
ART integration in already existing HIV/AIDS care pro-
gram. Establishing linkages with paediatric HIV/AIDS
care programs in order to enhance effectiveness of
PMTCT services is essential.
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